As the U.S. midterm elections draw closer, yet another poll finds that Americans remain very concerned about prescription drug pricing and are unhappy with how Washington is trying to resolve the issue.

Specifically, 77 percent regard drug costs as unreasonable and 65 percent report they are extremely or very concerned about prices, according to a poll of 1,022 adults Americans that was conducted last month by a pair of nonprofit research groups, the West Health Institute and NORC at the University of Chicago.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy